Targeted Treatment Breakthrough for Aggressive Childhood Brain Cancer
Today's Clinical Lab
New research identifies a critical genetic variation in Group 3 medulloblastomas, paving the way for improved diagnostic and treatment strategies for this challenging form of pediatric brain cancer